Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 6
1950 1
1951 3
1952 3
1953 1
1954 3
1955 4
1956 1
1957 1
1958 8
1959 5
1960 1
1966 2
1968 1
1971 1
1975 1
1977 1
1978 4
1979 1
1980 1
1981 5
1982 5
1983 4
1984 8
1985 6
1987 6
1988 8
1989 12
1990 10
1991 12
1992 18
1993 14
1994 12
1995 13
1996 11
1997 13
1998 15
1999 20
2000 18
2001 23
2002 15
2003 14
2004 22
2005 19
2006 17
2007 26
2008 19
2009 28
2010 35
2011 40
2012 41
2013 46
2014 45
2015 47
2016 49
2017 55
2018 47
2019 73
2020 87
2021 81
2022 82
2023 62
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,138 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancer.
Pfeifer M, Brammeld JS, Price S, Pilling J, Bhavsar D, Farcas A, Bateson J, Sundarrajan A, Miragaia RJ, Guan N, Arnold S, Tariq L, Grondine M, Talbot S, Guerriero ML, O'Neill DJ, Young J, Company C, Dunn S, Thorpe H, Martin MJ, Maratea K, Barrell D, Ahdesmaki M, Mettetal JT; Functional Genomics Centre; Brownell J, McDermott U. Pfeifer M, et al. Among authors: o neill dj. Commun Biol. 2024 Apr 24;7(1):497. doi: 10.1038/s42003-024-06190-w. Commun Biol. 2024. PMID: 38658677 Free PMC article.
Overcoming osimertinib resistance with AKT inhibition in EGFRm-driven Non-Small-Cell-Lung-Cancer with PIK3CA/PTEN alterations.
Grazini U, Markovets A, Ireland L, O'Neill D, Phillips B, Xu M, Pfeifer M, Vaclova T, Martin MJ, Bigot L, Friboulet L, Hartmaier R, Cuomo ME, Barry ST, Smith PD, Floc'h N. Grazini U, et al. Among authors: o neill d. Clin Cancer Res. 2024 Apr 17. doi: 10.1158/1078-0432.CCR-23-2540. Online ahead of print. Clin Cancer Res. 2024. PMID: 38630555
1,138 results